Hand Fiona, Sanabria Mateos Rebeca, Durand Michael, Fennelly David, McDermott Ray, Maguire Donal, Geoghegan Justin, Winter Des, Hoti Emir
Department of Hepatobiliary and Liver Transplant Surgery, St. Vincent's University Hospital, Dublin, Ireland.
Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland.
Dig Surg. 2018;35(6):514-519. doi: 10.1159/000485198. Epub 2018 Jan 18.
Local invasion of adjacent viscera by colorectal liver metastases (CRLM) is no longer considered an absolute contraindication to curative hepatic resection. A growing number of observational analyses have illustrated the feasibility of such resections; however, the evidence base is at best heterogeneous with a lack of evidence comparing similar patient groups. We aimed to evaluate the outcomes of hepatectomy for CRLM when combined with other viscera and compare to a matched cohort of isolated hepatic resections.
From 2005 to 2015, 523 patients underwent hepatic resection for CRLM at our institution, 19 of whom underwent hepatectomy with extrahepatic resection. A 3: 1 matched cohort analysis was performed between those who underwent isolated hepatectomy (control group) and those who underwent hepatectomy with extrahepatic resection (combined group). Clinicopathological data were reviewed along with 30-day postoperative morbidity and mortality. Furthermore, overall survival for the multivisceral cohort was compared to all other isolated hepatectomies over the same time period.
Nineteen patients underwent liver resection accompanied by either/or diaphragmatic resection (n = 13), major vein resection and reconstruction (n = 5), and visceral resection (n = 3). Maximum tumor size was significantly larger in the combined group (60.58 vs. 15.34 mm p < 0.0001). Postoperative morbidity was similar in both groups (p = 0.41). Following multivisceral resection, 1-, 3- and 5-year survival rates were 75, 56.6, and 25.7% respectively. Overall survival showed no significant difference between combined and control groups (p = 0.78). Similarly, when compared to the total cohort of isolated liver resections (n = 504), no significant difference in overall mortality was noted.
In patients presenting with concomitant CRLM and extrahepatic extension where R0 margins can be achieved, this present study supports the rationale to proceed to -surgery with comparable morbidity and mortality rates to -isolated hepatectomy.
结直肠癌肝转移(CRLM)对临近脏器的局部侵犯不再被视为根治性肝切除的绝对禁忌证。越来越多的观察性分析表明了此类切除的可行性;然而,证据基础充其量是异质性的,缺乏对相似患者群体进行比较的证据。我们旨在评估CRLM肝切除联合其他脏器切除的结局,并与匹配的单纯肝切除队列进行比较。
2005年至2015年,我们机构有523例患者因CRLM接受肝切除,其中19例接受了肝外切除的肝切除术。对接受单纯肝切除(对照组)和接受肝外切除的肝切除术(联合组)的患者进行了3:1匹配队列分析。回顾了临床病理数据以及术后30天的发病率和死亡率。此外,将多脏器切除队列的总生存期与同期所有其他单纯肝切除术进行了比较。
19例患者接受了肝切除,同时进行了膈肌切除(n = 13)、大静脉切除和重建(n = 5)以及脏器切除(n = 3)。联合组的最大肿瘤尺寸明显更大(60.58对15.34mm,p < 0.0001)。两组的术后发病率相似(p = 0.41)。多脏器切除后,1年、3年和5年生存率分别为75%、56.6%和25.7%。联合组和对照组的总生存期无显著差异(p = 0.78)。同样,与单纯肝切除的总队列(n = 504)相比,总死亡率无显著差异。
在伴有CRLM和肝外扩展且能实现R0切缘的患者中,本研究支持进行手术的合理性,其发病率和死亡率与单纯肝切除相当。